Firm Events
District Court vs. PTAB: Strategic Forum Selection in Life Sciences Patent Disputes
December 10, 2026 | 12:00 PM – 1:00 PM ET
The 41st Annual J. P. Morgan Healthcare Conference came and went this year in its usual flurry of activity, as health care and life sciences industry leaders converged on San Francisco to present on the most pressing issues and trends facing investors in the year to come. It was also the first time the annual conference was conducted in-person since the COVID-19 pandemic began.
The health care and life sciences industries experienced a difficult 2022, due to halted IPOs and plummeting valuations. Many companies found themselves at the end of their cash runways and were left with the difficult choice of either cutting back operations or seeking financing at a lower valuation to keep the lights on.
However, 2023 has a brighter outlook. Big Pharma is now on the hunt for innovation to replenish IP portfolios, and investors are seeing the promise of M&A and other strategic collaborations on the horizon.
After another insightful conference this year, these are some of the key legal deal trends to expect from the health care and life sciences industries in 2023.
Click here to read the full article on MedCity News.
Insight Industries + Practices
This just in
Speaking Engagements
Performance on Trial: The Construction Manager’s Standard of Care Examined from All Angles
December 2, 2026 | 4:15 PM – 5:30 PM ET
The Hyatt Regency Huntington Beach
Huntington Beach, CA
Speaking Engagements
ACI’s 31st Annual Conference on Drug & Medical Device Litigation – 2026
December 2 – 3, 2026
New York Marriott Marquis
1535 Broadway, New York, NY 10036
Speaking Engagements
Fundamentals of Investment Adviser Regulation 2026
November 19, 2026 | 2:30 PM – 3:30 PM ET
PLI New York
1177 Avenue of the Americas, Entrance on 45th Street, New York, NY 10036